EX-12.1 4 f78520a2ex12-1.txt EXHIBIT 12.1 EXHIBIT 12.1 SCICLONE PHARMACEUTICALS, INC. COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES (IN THOUSANDS)
THREE MONTHS ENDED YEAR ENDED YEAR ENDED YEAR ENDED YEAR ENDED YEAR ENDED MARCH 31, 2002 2001 2000 1999 1998 1997 -------------- ------------- ------------- -------------- -------------- -------------- FIXED CHARGES Interest expense $ 90 $ 334 $ 36 $ -- $ -- $ -- Portion of rent expense representing of interest 108 428 164 131 152 152 ----------------------------------------------------------------------------------------------- Fixed Charges 198 762 200 131 152 152 EARNINGS Net Loss before income taxes $ (2,403) $ (6,232) $ (1,717) $ (5,467) $ (24,214) (13,997) Fixed charges 198 762 200 131 152 152 ----------------------------------------------------------------------------------------------- Earnings (2,205) (5,470) (1,517) (5,336) (24,062) (13,845) Ratio of earnings to fixed charges n/m n/m n/m n/m n/m n/m
(1) We have computed the ratios of earnings to fixed charges by dividing income (loss) before income taxes plus fixed charges by fixed charges. For the periods presented, fixed charges consisted of interest expensed, capitalized expenses related to indebtedness, and the estimated portion of rental expense for operating leases that represents interest. Earnings were insufficient to cover fixed charges for the three months ended March 31, 2002 and the years ended December 31, 2001, 2000, 1999, 1998, and 1997 by approximately $2.4 million, $6.2 million, $1.7 million, $5.5 million, $24.2 million, and $14.0 million, respectively. (2) We currently have no outstanding preference equity securities.